These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8655212

  • 21. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S, Garza-González E, Camacho-Ortiz A, González GM, Llaca-Díaz JM, Bosques F, Rositas F.
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [Abstract] [Full Text] [Related]

  • 22. Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.
    Seeberg AH, Tolxdorff-Neutzling RM, Wiedemann B.
    Antimicrob Agents Chemother; 1983 Jun; 23(6):918-25. PubMed ID: 6351733
    [Abstract] [Full Text] [Related]

  • 23. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC.
    Scand J Infect Dis Suppl; 1993 Jun; 91():25-32. PubMed ID: 8290900
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in Argentina.
    Casellas JM, Goldberg M, Orellana N, Morosini MI, Negri MC, Arduino S.
    Infection; 1990 Jun; 18(3):193-5. PubMed ID: 2114372
    [Abstract] [Full Text] [Related]

  • 25. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
    Barnaud G, Labia R, Raskine L, Sanson-Le Pors MJ, Philippon A, Arlet G.
    FEMS Microbiol Lett; 2001 Feb 20; 195(2):185-90. PubMed ID: 11179650
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011.
    Hoban DJ, Badal R, Bouchillon S, Hackel M, Kazmierczak K, Lascols C, Hawser S.
    Diagn Microbiol Infect Dis; 2014 Jul 20; 79(3):367-72. PubMed ID: 24813688
    [Abstract] [Full Text] [Related]

  • 31. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
    Bakhtiar M, Selwyn S.
    Drugs Exp Clin Res; 1989 Jul 20; 15(10):477-82. PubMed ID: 2698794
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
    Rodríguez-Martínez JM, Fernández-Echauri P, Fernández-Cuenca F, Diaz de Alba P, Briales A, Pascual A.
    J Antimicrob Chemother; 2012 Jan 20; 67(1):64-8. PubMed ID: 22001269
    [Abstract] [Full Text] [Related]

  • 35. Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
    Jones RN.
    Diagn Microbiol Infect Dis; 1998 Jul 20; 31(3):461-6. PubMed ID: 9635237
    [Abstract] [Full Text] [Related]

  • 36. beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.
    Sanders CC.
    Antimicrob Agents Chemother; 1989 Aug 20; 33(8):1313-7. PubMed ID: 2802558
    [Abstract] [Full Text] [Related]

  • 37. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.
    Tzouvelekis LS, Tzelepi E, Prinarakis E, Gazouli M, Katrahoura A, Giakkoupi P, Paniara O, Legakis NJ.
    J Clin Microbiol; 1998 Jan 20; 36(1):266-8. PubMed ID: 9431962
    [Abstract] [Full Text] [Related]

  • 38. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K, Inoue E, Mitsuhashi S.
    Chemotherapy; 1995 Jan 20; 41(4):257-66. PubMed ID: 7555206
    [Abstract] [Full Text] [Related]

  • 39. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C, Poiată A, Bădicuţ I, Teodor A, Luca V, Grigore L, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2003 Jan 20; 107(3):595-8. PubMed ID: 14756068
    [Abstract] [Full Text] [Related]

  • 40. Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
    Luo Y, Yang J, Ye L, Guo L, Zhao Q, Chen R, Chen Y, Han X, Zhao J, Tian S, Han L.
    Microb Drug Resist; 2014 Aug 20; 20(4):264-9. PubMed ID: 24433026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.